-
41
Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
Published 2002Journal article -
42
-
43
-
44
-
45
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.
Published 2006Journal article -
46
The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.
Published 2003Journal article -
47
A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
Published 2005Journal article -
48
Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
Published 2001Journal article -
49
The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
Published 1999Journal article -
50
-
51
-
52
The role of cytotoxic chemotherapy in the management of aggressive and malignant pituitary tumors.
Published 1998Journal article -
53
Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
Published 2005Journal article -
54
-
55
-
56
-
57
-
58
Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Published 1998Journal article -
59
-
60
Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.
Published 2002Journal article